Please login to the form below
US and Canada
This page shows the latest US and Canada news and features for those working in and with pharma, biotech and healthcare.
The Final Frontier
But let’s talk about gabapentin. In Canada and the US, gabapentin is indicated as an adjunctive therapy for patients with epilepsy, who are not adequately controlled with conventional therapy. ... But what I do know is that the legalisation of medical
Latest news
-
Symkevi approval in Europe helps Vertex expand CF treatment
The new combination has shown greater efficacy than Orkambi and with fewer side effects. ... The new combination was approved by the FDA and is known as Symdeko in the US and Canada.
-
AZ rival to GSK’s COPD drug Anoro fails head-to-head test
At stake is a share of a big and expanding market for COPD therapies, estimated at well over $15bn in the US and top five EU markets alone in 2016 but ... Bevespi is a newer entrant, picking up its first OK in the US in 2016 and also approved in Canada,
-
Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance
line. Business leaders from the US, Canada, Japan and India issued a joint statement yesterday, which said that international businesses who are “heavily invested” in both the EU and the UK ... The American Chamber of Commerce to the EU, which
-
Maintenance OK boosts AstraZeneca’s Lynparza in Europe
In the US the situation is even more competitive, with all three drugs converging around second-line maintenance therapy. ... With the PARP inhibitors looking increasingly interchangeable from a clinical perspective, AZ enlisted the aid of MSD (known as
-
Sanofi’s latecomer PD-1 gets date for FDA verdict
The US regulator has given a priority review for PD-1-targeting cemiplimab because its first indication – cutaneous squamous cell carcinoma (CSCC) – is the second most common form of skin cancer ... Priority review for Keytruda in NSCLC. Meanwhile,
More from news
Approximately 0 fully matching, plus 240 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
US. US and Canada only. # US and EU. Roche’s collaboration with Ionis Pharmaceuticals has a headline of $760m, $1m more than the Tusk deal. ... milestones and royalties, and US profits or losses will be split 50:50.
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
She is Alnylam’s senior vice president, Europe and Canada and is based at the firm’s European headquarters in Zug, Switzerland. ... In the US and Canada, the company has launched Alynlam Act, a free of charge genetic testing and counselling service.
-
Deal Watch February 2017
In addition to the upfront and milestone payments, Immunomedics will receive tiered double digit royalties on global net sales, retains an option to co-promote IMMU-132 in the US and ... First approved in North America in 1989, Zoladex sales in 2016 were
-
2016: The year when deal-makers took stock?
Compounding this was the current political uncertainty following regime change in the US and Brexit, with the latter appearing to encourage caution in deal-making which may well continue into 2017. ... This has provided an opportunity for companies
-
Deal Watch October 2016
$4, 300 royalty. Buyout of collaboration. Respiratory 2015. Actavis US and Canada. ... The biosimilar market is heating up. This month Teva has entered into a US and Canada commercialisation arrangement with South Korea's Celltrion.
More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.
Latest appointments
-
NDA bolsters its senior team
US, Europe, Canada and other markets. ... Her contributions will help propel client strategy and accelerate programmes across the EU and US, as well as result in new intriguing service offerings that enable innovative companies to navigate the
-
Celgene’s president and COO to retire
Smith has over 30 years of business strategy experience across a range of therapeutic areas, having previously held senior leadership roles at Biovail in Canada, France, the US and Hong Kong, ... Smith's successor, Curran, joined Celgene in 2013 as the
-
Bayer appoints president of Americas pharma business
Dr Carsten Brunn to lead operations across the US, Canada, Central and Latin America. ... Bayer has appointed Dr Carsten Brunn as the president of its pharmaceuticals business in the Americas, overseeing the company's operations in the US, Canada and
-
Vikas Sinha joins Verona as non-executive director
Brings strong US and financial experience to the UK drug development firm. ... Prior to that he spent 11 years at Bayer, holding roles in the US, Canada, Japan and Germany, latterly as chief financial officer for Bayer Pharmaceuticals Corporation in the
-
Merck appoints new North America and China biopharma leaders
He will be responsible for the Massachusetts-based biopharma business' strategic direction and growth across the US and Canada. . ... chief commercial officer for the US.
More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest from PMHub
-
Valuable Foresights on How Bariatric Surgery Devices Market will Grow During 2015-2025
This results more consumption of bariatric surgery devices by hospitals and weight-loss clinics. ... in the US and Canada.
-
Acute leukaemia patients get new online information centre that will help them get the best possible care
access to new treatments and clinical trials often depends on where they live. ... Most importantly, the panel of experts from the UK, Italy, France, Spain, Germany, Canada and the US provides insights into how to get the best from a healthcare team,
-
Acute leukaemia patients get new online information centre that will help them get the best possible care
Most importantly, the panel of experts from the UK, Italy, France, Spain, Germany, Canada and the US provides insights into how to get the best from a healthcare team, including what ... Visit us on: www.patientpower.eu . Follow us on
-
GCI Health launches global medical education offer with new appointment
She has previously held leadership roles at HealthEd, Delta Kn and TVF Communications. . ... US, Canada and Europe, our client roster spans broadly across many sectors in healthcare, including pharmaceutical, biotech, medical technology, consumer health
-
GCI Health makes senior promotions and expands team with an additional two hires
Specialist healthcare communications agency GCI Health makes two senior promotions and the agency continues to expand following two new hires. ... relations. With more than 140 professionals across the US, Canada and Europe, our client roster spans
More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.
Featured jobs
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director, Medical Education
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
-
Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Senior Medical Writer
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Immunomedics craters after FDA rejects breast cancer ADC
- NHS England sees off AbbVie's Hep C legal challenge
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- Novartis forges AI alliance with Oxford University
- J&J earnings top expectations, but feels the squeeze in US
- Researchers reverse Alzheimer’s memory loss in mice
- Editas CEO exits the CRISPR firm ahead of first clinical trial
- A dynamic and challenging environment – what it’s like starting a career in MedComms
- UniQure cleared to start Huntington gene therapy trial
- HSJ Partnership Awards 2019 shortlist announced
PMHub
Ashfield
Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...
Latest intelligence
- Unlocking the potential of science and technology in the UK
- Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
Quick links
Infographics
